Stem cells preserve their identities after cell division by using a series of protein "bookmarks" on their genes, according to new research published by scientists at Weill Cornell Medicine.
A compound identified by Weill Cornell Medicine scientists inhibits the growth of a rare blood cancer found in people with HIV-AIDS.
At the 37th Annual Vincent du Vigneaud Memorial Symposium April 18, posters displayed research from students at every stage along the path to a doctorate.
Up to 30 percent of HIV patients who are appropriately treated with antiretroviral therapies develop emphysema. New research from Weill Cornell Medicine investigators has uncovered a mechanism that might explain why this lung damage occurs.
The Bench to Bedside Initiative program, part of Weill Cornell Medicine's entrepreneurship lab, helps medical and doctoral students, clinicians and researchers launch technologies into startups.
Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center researchers have developed a preclinical model of colorectal cancer in which the disease forms in the correct anatomical location.
Dr. Arjun Srinivasan of the CDC delivered the keynote lecture at the symposium, "Antimicrobial Resistance: Research Synergies in Human and Animal Medicine," on Cornell's Ithaca campus May 4.
A study identified the sugar alcohol erythritol, which can be metabolized by, and even produced in, the human body as a biomarker for increasing fat mass.
Kathleen M. Rasmussen, professor of nutritional sciences, has been recognized by the American Society for Nutrition with the Conrad A. Elvehjem Award for Public Service in Nutrition.